Clinical Trials Directory

Trials / Completed

CompletedNCT03549546

Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Postoperative pneumonia is one of the most common complications after lung cancer surgery and associated with a morbidity and mortality. Postoperative lymphopenia has been recently identified as one of risk factors for postoperative pneumonia. According to recent studies in polytrauma, cancer or septic shock, T cells dysfunction may be related to high expression of inhibitory receptors on lymphocytes.

Detailed description

This study will investigate prospectively TIM-3, PD-1 and CTLA4 expression on lymphocytes T cells before and after lung cancer surgery. Patients ≥ 18 years with no history of immunosuppressive state will be included.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood samplesBlood samples will be collected in patients undergoing lung cancer surgery: * before lung cancer surgery, * the next day lung cancer surgery, * 3 days after lung cancer surgery. They will be treated in flow cytometry.

Timeline

Start date
2018-06-14
Primary completion
2019-02-06
Completion
2019-02-12
First posted
2018-06-08
Last updated
2019-07-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03549546. Inclusion in this directory is not an endorsement.